(Q40436486)

English

Neuroborreliosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Neuroborreliosis (English)

1 reference

Europe PubMed Central

20 September 2017

0 references

John J Halperin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

John J Halperin

1

1 reference

Europe PubMed Central

20 September 2017

publication date

24 November 2016

1 reference

Europe PubMed Central

20 September 2017

Journal of Neurology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

264

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1292-1297

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

https://scigraph.springernature.com/pub.10.1007/s00415-016-8346-2

0 references

Lyme borreliosis-associated encephalopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Lyme disease of the brainstem.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Pseudotumor cerebri: early manifestation of adult Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Chronic neurologic manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Central nervous system abnormalities in Lyme neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Risk factors for a non-favorable outcome after treated European neuroborreliosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Long-term Outcomes of Persons With Lyme Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Long-term outcome of Lyme disease in children given early treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00415-016-8346-2

21 January 2018

Pseudotumor cerebri in Lyme disease: a case report and literature review

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lyme neuroborreliosis. Peripheral nervous system manifestations

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27885483

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-016-8346-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27885483%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40436486&oldid=1897800118"